ArticleBlood advances2026

Class 3 MAP2K1 mutations associate with relapse and multiple treatment lines in multisystem Langerhans cell histiocytosis.

Kevin D Hofer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.